No abstract

No abstract

This present work deals with the synthesizes of nine novel thiosemicarbazone copper(II) complexes {[Cu(L) 2 ]Cl C3, [Cu(L)(bpy)]Cl C4-C6, [Cu(L) (phen)]Cl C7-C9 (where, L = H(L1)-H(L3), H(L1) = (E)-N-methyl-2-(1-phenyl-2-((5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)ethylidene)hydrazinecarbothioamide, H(L2) = (E)-N-ethyl-2-(1-phenyl-2-((5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)ethylidene) hydrazinecarbothioamide, H(L3) = (E)-N-phenyl-2-(1-phenyl-2-((5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)ethylidene) hydrazinecarbothioamide, bpy = 2,2′-bipyridyl and phen = 1,10-phenanthroline) with improved pharmacological results. The synthesized complexes were characterized by various spectral-analytical techniques. The structure of the copper(II) complexes C1-C9 was proposed by EPR spectroscopy. It confirmed the square planar coordination around Cu(II) complexes. The antibacterial screening of the complexes revealed that complexes C7 and C8 demonstrated significant activity against Gram-positive (B. thuringiensis) and Gram-negative (E. coli) bacteria. The concentration-dependent DNA cleavage activity of supercoiled (SC) pUC18 DNA exhibited complete DNA degradation effect on complex C6 at a minimum concentration of 40 μM. In vitro cytotoxic results showed that the mixed ligand copper(II) complexes C4, C5 and C7 exhibited higher effects on human cervical cancer cell lines, HeLa, when compared to cisplatin. Hence, the results obtained from each biological screening indicated the superior biological efficacy of the mixed ligand copper(II) complexes bearing diimine moieties. It could be considered as a promising alternative to an existing anticancer drug.

The objective of the work is to investigate the influence of fluoride in the bioactivity of phosphate bio-glass to utilise in bone tissue engineering. The fluorophosphate bio-glass system was formulated by varying fluoride content in phosphate-based glass 45P2O5-(30-X)-CaO-25Na2O-XCaF2 (X = 0, 1.25, 2.5, 3.75, and 5.0) using melt quenching technique. The elemental composition and fluoride retention in the prepared material was investigated by X-ray photoelectron spectroscopy. The bioactivity test in simulated body-fluid (SBF) exhibited apatite layer and its bone bonding ability which was characterized by X-ray diffraction patterns and Fourier Transform Infrared Spectrophotometer spectra. The viability of human gastric adenocarcinoma (AGS) and MG-63 cells of the bio-glass confirmed the nontoxic nature. In vivo studies demonstrated the conversion of the fluorophosphate glass to bone in the femoral condyle of the rabbit. After ten weeks, scanning electron microscope with energy dispersive X-ray spectrograph (SEM_EDAX) and confocal laser scanning microscopy examinations revealed the resorption rate and bone-glass interface qualitatively and quantitatively. Consequently, the biocompatible and bioresorbable nature of the fluorophosphate bioglass can be exploited as a potential bone graft substitute in the near future.